glp-1 drugs safety risks in the market: an update on weight loss medication, May 2026 – Partnership for Safe Medicines Long-term Success of GLP-1s Hinges

Phase 2 trials showed people losing up to 10.8% of body weight with cagrilintide alone - and that's without combining it with other medications

10.1210/endo-122-3-976 Endocrinology 11 BellanceN.BenardG.FurtF.BegueretH.SmolkovaK.PasserieuxE.et al (2009)

It demonstrated an efficacy and safety profile consistent with currently available GLP-1 RAs like Wegovy in adults with T2DM

EBioMedicine 24, 159165

You may also reach out to any of our physical outlets to place a same day delivery order Self-pickup orders will not be ready on the same day the order is placed

WHY ITS IMPORTANT TO ASK QUESTIONS If youre receiving B12 injections - or planning to - its perfectly OK to ask your practitioner what type of B12 theyre using